C19O2-Steroid transformations in the human normal, hyperplastic and cancerous prostate.
D015113:Androstane-3,17-diol / Q000378:metabolism*; D000732:Androstanols / Q000378:metabolism*; D013196:Dihydrotestosterone / Q000378:metabolism*; D006801:Humans; D006913:Hydroxysteroid Dehydrogenases / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D006899:Mixed Function Oxygenases / Q000378:metabolism; D009249:NADP; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000378:metabolism; D011467:Prostate / Q000378:metabolism*; D011470:Prostatic Hyperplasia / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000378:metabolism*; D013739:Testosterone / Q000378:metabolism*
D000732:Androstanols; D013196:Dihydrotestosterone; D015113:Androstane-3,17-diol; D013739:Testosterone; D009249:NADP; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases; D006913:Hydroxysteroid Dehydrogenases